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The Transcription Factor c-Maf Controls
the Production of Interleukin-4
but Not Other Th2 Cytokines
Kopf et al., 1993; Kaplan et al., 1996; Shimoda et al.,
1996; Takeda et al., 1996). As such, IL-4 plays a central
role in the regulation of allergic and humoral immune
responses. Recent data, however, suggest that another
Th2 cytokine, IL-13, may play an equally important role
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in the pathogenesis of allergic asthma (Grunig et al.,²Department of Medicine
1998; Wills-Karp et al., 1998). Further, T cells from miceHarvard Medical School
that lack IL-4 have greatly reduced but not absent levelsBoston, Massachusetts 02115
of two other Th2 cytokines, IL-5 and IL-10, raising the
possibility that IL-4-independent mechanisms to gener-
ate Th2 cells exist. Further, the expression of Th2 cyto-Summary
kines is not entirely coordinately regulated since it is
possible to generate Th2 clones that produce only IL-4IL-4 promotes the differentiation of naive CD41 T cells
or only IL-10 and not both (Kuchroo et al., 1995).into IL-4-producing T helper 2 (Th2) cells. Previous
Over the last few years, significant progress has beenwork provided suggestive but not conclusive evidence
made in identifying the transcription factors that controlthat the transcription factor c-Maf directed the tissue-
the transition of a Thp to a Th2 cell as evidenced byspecific expression of IL-4. It was not known whether
the capacity of such factors to drive IL-4 productionc-Maf controlled the transcription of other Th2 cyto-
(reviewed in Glimcher and Singh, 1999). We have shownkine genes. To elucidate the role of c-Maf in vivo, we
that the provision of three distinct proteins, the c-Mafexamined cytokine production in mice lacking c-Maf
protooncogene, the transcription factor nuclear factor(c-maf2/2). CD41 T cells and NK T cells from c-maf2/2
of activated T cells (NFAT), and a novel nuclear antigen,mice were markedly deficient in IL-4 production. How-
NFAT-interacting protein 45 kDa (NIP45), confers on aever, the mice produced normal levels of IL-13 and
non-T cell the ability to produce endogenous IL-4 (HoIgE, and, when differentiated in the presence of exoge-
et al., 1996; Hodge et al., 1996a). These factors andnous IL-4, c-maf2/2 T cells produced approximately
others such as GATA-3 and Stat6 clearly can drive thenormal levels of other Th2 cytokines. We conclude
production of IL-4 and therefore the development of Th2that c-Maf has a critical and selective function in IL-4
cells both in vitro and in vivo. Thus, mice overexpressinggene transcription in vivo.
GATA-3 have an increased Th2 compartment (Zheng
and Flavell, 1997). GATA-3, unlike c-Maf, however, likely
does not directly regulate IL-4 transcription (Ouyang etIntroduction
al., 1998), although it clearly can transactivate the IL-5
gene in the presence of signals such as dibutyryl cyclicNewly activated CD41 T helper cells differentiate into
AMP and PMA (Lee et al., 1993; Yamagata et al., 1997;at least two functionally distinct subsets as defined by
Zhang et al., 1997; Ouyang et al., 1998). It may insteadtheir heterogeneous pattern of cytokine expression. Th1
act as a chromatin remodeling factor, to make the IL-cells produce IFNg and lymphotoxin while Th2 cells pro-
4/IL-5 locus accessible, thus effecting a global controlduce IL-4, IL-5, IL-6, IL-10, and IL-13 (Mosmann et al.,
of Th2 cytokine production.1986; Paul and Seder, 1994). The outcome of the immune
c-Maf, the cellular homolog of the avian viral onco-response mounted by an organism to a given pathogen,
gene v-maf, belongs to the AP-1 family of basic region/
be it an infectious agent, an autoantigen, or an allergen,
leucine zipper factors and binds to a consensus site
is heavily influenced by the patterns of cytokines it elic-
(MARE) in the proximal IL-4 promoter. c-Maf is ex-
its. For example, a successful battle against the Leish- pressed in Th2 but not Th1 clones and is induced during
mania major parasite occurs in mice that respond to normal differentiation of Thp cells along a Th2 but not
infection with a Th1-type cytokine profile, while over- Th1 pathway (Ho et al., 1996). Ectopic expression of
whelming infection leading to death occurs in mice that c-Maf in virtually any cell, including Th1 cells, B cells,
mount a Th2-type response to this pathogen (Heinzel nonlymphoid cells and yeast, transactivates the IL-4
et al., 1989). These outcomes can be directly attributed promoter (Ho et al., 1996, 1998; unpublished data). While
to the cytokines themselves since treatment with anti- we had shown that c-Maf was a potent transactivator
bodies to IFNg or to IL-4 reverses them (Sadick et al., of the IL-4 gene in vitro, the function of c-Maf during
1990). Th cell differentiation in vivo was unknown. We have
The Th2 cytokine IL-4 is a particularly important regu- recently garnered evidence for the critical role of c-Maf
lator of the immune response. IL-4 production is critical in controlling IL-4 production in vivo by overexpressing
to the differentiation of Th precursor cells (Thp) into c-Maf using a transgenic approach. c-Maf transgenic
mature effector Th2 cells. Mice lacking IL-4 or Stat6, mice have an increased Th2 immune response in vivo
the downstream signaling factor for IL-4, do not develop and in vitro that can be ablated by backcrossing onto
appreciable numbers of Th2 cells (Kuhn et al., 1991; an IL-4-deficient background (Ho et al., 1998).
These experiments provided suggestive but not con-
clusive evidence that c-Maf was necessary for the tran-³ To whom correspondence should be addressed (email: lglimche@
hsph.harvard.edu). scription of the IL-4 gene in vivo. Further, the role of
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left panel). Although in two of five experiments wt T cells
did not produce IL-4 (which is not unexpected given the
background 129/Sv strain), in none of the five experi-
ments did c-maf2/2 T cells produce IL-4. Whole spleen
cultures contain both naive and memory T cells, and it
was possible that the lack of IL-4 in vivo in the c-maf2/2
mice had skewed the T cell compartment to favor the
formation of memory Th1 cells. We therefore repeated
these experiments using naive Thp cells and observed
a similar lack of IL-4 production in activated c-maf2/2 T
cells when highly purified sorted naive T helper cells
were used (Figure 1B, left panel). We note that c-Maf1/2
mice have no detectable phenotype in terms of altered
secretion of Th cytokines in any of our assays.
The difference in IL-4 production could not be attrib-
uted to a variation in overall cell proliferation since
growth responses to anti-CD3 stimulation were equiva-
lent in c-maf2/2 and wild-type mice (data not shown).
Furthermore, the proliferation of splenocytes, lymph
node cells, and thymocytes, either alone or in combina-
tion with coactivators such as Concanavalin A, anti-
CD3, lipopolysaccharide, anti-IgM, and anti-CD40 wereFigure 1. Impaired Production of IL-4 in c-maf2/2 Mice
equivalent in both c-maf2/2 mice and wild-type miceImpaired production of IL-4 in unskewed (left panels) and in Th2-
(data not shown).skewed (right panels) conditions upon secondary stimulation of
c-maf2/2 spleen cells from (A) whole splenocytes and (B) purified
naive CD41 T cells. For unskewed conditions, freshly isolated splen- Exogenous IL-4 Treatment Restores Some IL-4
ocytes from wild-type or c-maf2/2 mice were cultured at 2 3 106
Production in c-maf2/2 Spleen Cells but Verycells/ml with 1 mg/ml of plate-bound anti-CD3 for 7 days, washed,
Little IL-4 from Thp Cellsand restimulated for 48 hr with anti-CD3. For Th2-skewed condi-
Since IL-4 itself is required for the generation of Th2tions, cells were stimulated in the presence of exogenous IL-4 during
the 7 day incubation. IL-4 was measured by ELISA in supernatants cells (Kuhn et al., 1991), it was possible that the failure
taken at 48 hr. Naive CD41 T cells were isolated by CD4 FITC/MEL- of the c-maf2/2 T cells to produce IL-4 was in part sec-
14 PE antibody staining and MoFlo purification. ondary to the absence of sufficient IL-4 to initiate the
Th2 program. We therefore asked whether the defect
c-Maf in driving the production of other Th2 cytokines in IL-4 production in the absence of c-Maf could be
remained unclear. To address these issues, we have overcome by the addition of exogenous IL-4. c-maf2/2
generated by a standard gene disruption approach mice splenocytes differentiated under this Th2-skewing con-
that lack c-maf. The initial characterization of a severe dition were able to produce some IL-4, but the amounts
lens defect in these mice is described elsewhere (Kim were substantially reduced (70.1% decrease 6 21%)
et al., 1999). Here, we report that c-maf2/2 mice demon- compared to wild-type (Figure 1A, right panel). When
strate a severe impairment in the expression of IL-4 both highly purified naive T helper cells rather than spleen
in Th2 cells and in NK1.1 T cells. Interestingly, spleen cells were used as the starting population, however,
cells from c-maf2/2 mice produced normal levels of IL- very little IL-4 was produced by c-maf2/2 T cells (Figure
13 and IgE and when differentiated in the presence of 1B, right panel). We conclude that c-Maf is essential for
exogenous IL-4 produced virtually wild-type levels of the production of normal amounts of IL-4 but that other
other Th2 cytokines. We conclude that c-Maf has a criti- IL-4-responsive factor(s) can contribute to IL-4 gene
cal and selective function in the transcription of the IL-4 transcription, likely produced by non-T cells or from
gene in vivo.
memory CD41 cells, in the absence of c-Maf. Two attrac-
tive candidates are the Stat6 and GATA-3 transcription
Results and Discussion
factors, both of which are responsive to IL-4 (Kaplan et
al., 1996; Shimoda et al., 1996; Takeda et al., 1996; Zhang
Severe Impairment in IL-4 Production
et al., 1997; Zheng and Flavell, 1997). Indeed, ectopicin c-Maf-Deficient T Cells
expression of c-Maf in Th1 cells does not permit themUpon signaling through the T cell receptor, the very
to produce IL-4, a finding that is consistent with a rolelow levels of c-Maf present in T helper precursor cells
for other transcription factors in driving IL-4 productionincrease in cells that progress along a Th2 but not Th1
(Ho et al., 1998). Studies to test the hypothesis thatpathway (Ho et al., 1996). c-Maf is a potent transactivator
ectopic expression of both c-maf and GATA-3 trans-of the IL-4 promoter and together with two other pro-
genes in Th1 cells will permit IL-4 gene transcription areteins, NFAT and NIP45, confers on a nonproducer cell
ongoing.the ability to make endogenous IL-4 (Hodge et al.,
1996a). To determine whether and to what extent c-Maf
c-Maf Controls the Production of IL-4 in NK T Cellscontrols the production of IL-4 in vivo, whole spleno-
IL-4 is produced by multiple cell types including Th2cytes or purified naive Thp cells from wild-type (wt) and
cells, mast cells, basophils, and a small population ofc-maf2/2 mice were stimulated in culture with anti-CD3
CD41 T cells that bear the NK1.1 surface marker (Yoshi-under nonskewing conditions. Virtually no IL-4 was de-
tected in supernatants from c-maf2/2 cells (Figure 1A, moto and Paul, 1994). Although this small CD41NK1.11
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mRNA detectable 90 min after treatment (Figure 2). We
conclude that c-Maf plays a critical role in driving the
transcription of the IL-4 gene in both classic Th2 cells
and in CD41NK T cells. It has been postulated that NK
T cells provide an important, although not required, early
source of IL-4 that initiates the Th2 program in response
to antigen (Bendelac et al., 1996; Brown et al., 1996;
von der Weid et al., 1996; Zhang et al., 1996; Smiley et
al., 1997). c-Maf appears to be an important component
of this pathway.
Figure 2. Decreased Production of IL-4 in NK T Cells
c-maf2/2 or wt littermates were injected i.v. with PBS or 4 mg of c-Maf Does Not Control the Production
anti-CD3. Total cellular RNA (10 mg) prepared from spleens was
of Other Th2 Cytokinesfractionated in 1.2% agarose gels, blotted onto nylon membranes,
c-Maf, therefore, directly controls the transcription ofand hybridized. Hybridization to an IL-4 cDNA probe revealed im-
the IL-4 gene both in Th2 cells and in NK T cells, butpaired induction of transcripts encoding IL-4 in c-maf2/2 spleen
cells. Filters were stripped and rehybridized with a g-actin cDNA its role in regulating the expression of other Th2 cyto-
probe to control for amount of RNA loaded per lane. IL-4 film and kines was not known. To examine the role of c-Maf in
g-actin film were exposed for 12 hr and 1 hr, respectively. Densitom- regulating the expression of other Th2 cytokines, whole
etry shows a 23 to 43 decrease in 2/2 lanes when normalized for
splenocytes or purified naive Thp cells from wt andloading.
c-maf2/2 mice were stimulated in culture with anti-CD3
under nonskewing conditions as above. Other Th2 cyto-
kines, IL-5, IL-6, and IL-10 were present, albeit in verypopulation of T cells represents only approximately 1%
of splenocytes, it accounts for virtually all of the IL-4 reduced amounts, in supernatants from unskewed acti-
vated c-maf2/2 spleen cell cultures (Figures 3A and 3B,produced in response to in vivo challenge with anti-CD3
(Yoshimoto and Paul, 1994; Bendelac et al., 1996). This left panels). It is interesting to note that levels of IFNg
were slightly elevated in c-maf2/2 cultures (approxi-population could conceivably have accounted for the
IL-4 produced in unfractionated c-maf2/2 spleen. To test mately 50% increase). Two possible explanations for
the elevation in IFNg levels can be considered. First, thewhether c-Maf is important in the initial regulation of
IL-4 in NK T cells, wt and c-maf2/2 mice were injected diminished levels of IL-4 in c-maf2/2 mice should allow
increased formation of Th1 cells since IL-4 inhibits thewith antibodies to CD3; the peak of IL-4 expression is
seen at 90 min post injection. RNA prepared from spleen Th1 pathway. Alternatively, we have recently demon-
strated that ectopic expression of c-Maf in Th1 cellscells from anti-CD3-injected control mice contained
large amounts of transcripts encoding IL-4 as expected. represses IFNg production by a mechanism that is IL-4
independent (Ho et al., 1998). The absence of c-MafIn contrast, anti-CD3-injected c-maf2/2 mice exhibited
a striking defect in the induction of IL-4 with little or no would be expected to relieve that repression.
Figure 3. Defective Production of Other Th2
Cytokines in c-maf2/2 Mice in Unskewed
Conditions Is Restored by Addition of Exoge-
nous IL-4
Supernatants from differentiated cultures of
(A) whole splenocytes or (B) purified naive
CD41 T cells under unskewed (left panels)
and in Th2-skewed (right panels) conditions
upon secondary stimulation were analyzed
by ELISA. Mean level of cytokine production
is shown as a horizontal bar. IL-13 was not
detected in any of the supernatants of the
purified naive cells. Five wt mice were ana-
lyzed for (A) and two wt mice for (B). The
closed bars represent wt mice, and the open
bars represent c-maf2/2 mice.
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Figure 4. c-Maf Does Not Transactivate the IL-5 or IL-10 Promoters
M12 cells were cotransfected with luciferase reporter plasmids,
driven by IL-5 (IL-5 Luc), IL-10 (IL-10 Luc), or IL-4 (IL-4 Luc) promot-
ers, together with a c-Maf expression vector (c-Maf) or the control
empty expression vector (vector). Promoter activity was quantitated
by luciferase assay 24 hr post transfection. The promoter-luciferase
Figure 5. Diminished IgG1 and IgG2a and Normal IgE Antibody Re-activity observed by transfection of the empty expression vector
sponses in c-maf2/2 Micewas normalized to 1.
Mice were immunized with DNP-OVA in complete Freund's adjuvant
and levels of OVA-specific Ig quantitated by ELISA 14 days later
(Kaplan et al., 1996). Horizontal bars indicate mean values.
These results are consistent with a direct effect of
c-Maf in controlling IL-5, IL-6, and IL-10 gene transcrip-
Levels of IL-13 and IgE Are Normal in c-maf2/2 Mice
tion. However, we believed it was more likely that the
IL-13 is a recently described cytokine that is primarily
decreased production of other Th2 cytokines reflected
produced by Th2 cells (Brown et al., 1989; McKenzie et
the absence of IL-4 and hence impaired Th2 develop-
al., 1993; Minty et al., 1993). In vitro studies have shown
ment rather than a direct transcriptional effect of c-Maf.
that IL-13, like IL-4, activates B cells, induces immuno-
We therefore asked whether the defect in IL-4 produc-
globulin isotype class switching to IgE in human B cells
tion in the absence of c-Maf could be overcome by the
(McKenzie et al., 1993; Punnonen et al., 1993; Defrance
addition of exogenous IL-4 as above. Indeed, addition et al., 1994), and downmodulates cytotoxicity and in-
of exogenous IL-4 to unfractionated spleen cell cultures flammatory cytokine production by macrophages (Doh-
markedly restored the production of Th2 cytokines (Fig- erty et al., 1993; de Waal Malefyt et al., 1993). This over-
ure 3A, right panel). The lack of complete restoration lap of biological activity by IL-13 and IL-4 has been partly
likely reflects a diminished compartment of memory Th2 explained by studies showing that these two cytokines
compared to memory Th1 cells secondary to in vivo share the IL-4 receptor a chain (Aversa et al., 1993;
absence of IL-4 that cannot be completely reversed by Zurawski et al., 1993). Additional studies have demon-
addition of exogenous IL-4 in vitro. Indeed, when naive strated cross-regulation between IL-13 and IL-4 (Punno-
Thp cells were isolated and cultured in the presence of nen et al., 1993; Barner et al., 1998; Emson et al., 1998).
exogenous IL-4, full restoration of Th2 cytokine produc- Treatment of mice with a polyclonal anti-mIL-13 anti-
tion was achieved (Figure 3B, right panel). body resulted in decreased IL-4 production by antigen-
specific splenocytes in response to immunization (Bost
et al., 1996), suggesting that inhibiting IL-13 function
c-Maf Does Not Transactivate the IL-5 results in impaired IL-4 expression. Furthermore, IL-13-
or IL-10 Promoters deficient mice have impaired development of Th2 cells
To further examine the possibility that c-Maf controls with significantly decreased IL-4 production (McKenzie
the transcription of other Th2 cytokines, we tested the et al., 1998). Recent experiments demonstrate that it is
ability of c-Maf to transactivate the IL-5 and IL-10 pro- the combination of IL-4 and IL-13 that contributes to
moters. Regulatory regions for the IL-5 and IL-10 genes the pathogenesis of experimental asthma and to the
have begun to be delineated, and it is clear, for example, response against experimental intestinal helminth infec-
that GATA-3 can transactivate the IL-5 promoter (Lee tions and Schistosoma mansoni (Grunig et al., 1998;
et al., 1993; Yamagata et al., 1997; Zhang et al., 1997; Wills-Karp et al., 1998; Chiaramonte et al., 1999).
Ouyang et al., 1998). Constructs containing the IL-5 and We wished to determine whether c-Maf regulated the
IL-10 promoters fused to a luciferase reporter were co- expression of the IL-13 gene, and if not, whether the
transfected with a c-Maf expression plasmid into the impaired production of IL-4 would affect levels of IL-13
M12 B lymphoma as described previously (Ho et al., and/or the generation of an IgE response. Interestingly,
1996; Hodge et al., 1996a). c-Maf could transactivate levels of IL-13 produced by c-maf2/2 T cells, either in
neither the IL-5 nor IL-10 promoters in contrast to its the presence or absence of exogenous IL-4, were com-
potent transactivation of the IL-4 promoter (Figure 4); pletely normal (Figure 3). Further, examination of serum
GATA-3, however, did transactivate the IL-5 promoter Ig levels of unimmunized and DNP-OVA-immunized
in the presence of dbcAMP and PMA (data not shown). c-maf2/2 mice revealed a modestly impaired production
We conclude that c-Maf selectively directs the transcrip- of both IgG1and IgG2a antibody but normal levels of
tion of the IL-4 gene and that Th2 cytokines must utilize IgE antibody (Figure 5). Although we cannot absolutely
extrapolate from in vitro data to the in vivo situation, thedyscoordinate control mechanisms.
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anti-CD3. Forty-eight hours post restimulation, supernatants werenormal levels of IL-13 may account for the unimpaired
harvested and cytokines measured by ELISA.production of IgE in c-maf2/2 mice (Punnonen et al.,
1993; Barner et al., 1998; Cohn et al., 1998; Emson et
In Vivo Anti-CD3e Analysisal., 1998), although mice lacking IL-4 do have impaired
Five-week-old c-maf2/2 and wt littermate mice were injected with
production of the IgG1 and IgE isotypes (Finkelman et 100 ml PBS or PBS containing 4 mg of purified anti-CD3e (145-2C11)
al., 1988; Kuhn et al., 1991). Alternatively, CD4 T cell- antibody into the tail vein (Yoshimoto and Paul, 1994). At 90 min
post injection, mice were sacrificed, spleens snap frozen in liquidindependent mechanisms of IgE production may be op-
N2, RNA prepared by the guanidinium/CsCl method, and 10 mg frac-erative (Noben-Trauth et al., 1997; Hogan et al., 1998).
tionated by electrophoresis on 1.2% agarose/6% formaldehydeWe conclude that c-Maf does not control the expression
gels. Filters were hybridized with at least 1 3 106 cpm of randomof the IL-13 gene. It is surprising that IL-13 levels, unlike
primer labeled cDNA fragments purified from the IL-4 or g-actin
the other Th2 cytokines, were not reduced in c-maf2/2 plasmids.
cells in the absence of exogenous IL-4. This result could
be explained by postulating that cells other than Th2 Measurement of Cytokine and Antibody Levels by ELISA
Supernatants were assayed for levels of IL-2, IL-4, IFNg, IL-6, IL-cells in the mouse produce IL-13. For example, human
10, IL-13, and IL-5 by ELISA (PharMingen) as previously describedNK cells have recently been shown to produce IL-13
(Hodge et al., 1996b). Eight-week-old mice were injected subcutane-(Hoshino et al., 1999). Alternatively, the normal produc-
ously with 100 mg of DNP-OVA in complete Freund's adjuvanttion of IL-13 in c-maf2/2 mice raises the intriguing possi-
(Sigma). Serum was taken at day 14 post injection and analyzed by
bility that there exist subsets of IL-13-producing Th2 ELISA. For ELISA, Nunc Immuno plates were coated with 1 mg/ml
cells whose formation is IL-4 independent (Cohn et al., goat-anti-mouse IgG1, IgG2a, and IgE (Southern Biotechnology).
Bound antibodies in sera were detected with alkaline-phosphatase-1998). The production of long-term clones from c-maf2/2
coupled isotype-specific goat-anti-mouse antibodies (SouthernT cells may clarify these issues.
Biotechnology). Serum immunoglobulin concentrations were deter-In conclusion, the analysis of mice lacking c-Maf has
mined as previously described (Kaplan et al., 1998).demonstrated a critical and nonredundant function for
this Th2-specific transcription factor in controlling the
Plasmids and Transfection Assays
expression of the IL-4 gene in vivo. While other, IL-4- The murine B cell line, M12.4.1, was maintained in RPMI supple-
responsive, factors such as GATA-3 and Stat6 may con- mented with 10% FCS. For each transfection, 5 3 106 cells were
washed once with RPMI, resuspended in 400 mL RPMI, transferredtribute to the transcription of the IL-4 gene, they cannot
to 0.4 cm electrocuvettes, and incubated with 10 mg of each plasmidsubstitute for c-Maf. Our data demonstrate that c-Maf
DNA at room temperature. Cells were then electroporated at 280V/is necessary for the production of normal amounts of
975 mF and left at room temperature for 10 min prior to transfer toIL-4 in vivo. Further, in contrast to GATA-3, c-Maf does
5 ml of complete medium. Twenty-four hours post electroporation,
not globally control all Th2 cytokines but selectively whole cell extract was harvested and subjected to luciferase assay.
regulates IL-4. In particular, the transcription of the IL- The IL-5 promoter reporter construct, IL-5Luc, contains 507 bp of
sequence upstream of the murine IL-5 gene and was the gift of13 gene, the Th2 cytokine that most closely resembles
T. Baumruker (Csonga et al., 1998) (Novartis). The IL-10 reporterIL-4 in function, is c-Maf independent. The dyscoordi-
promoter, IL-10Luc, which contains 1536 bp upstream of the humannate transcriptional regulation of Th2 cytokines revealed
IL-10 gene, was kindly provided by Dr. Steven Smale (UCLA). Thehere suggests the existence of more specialized subsets
IL-4 promoter reporter construct, IL-4Luc, which contains 807 bp
of Th2 cells. The availability of c-maf2/2 T cells should upstream of the murine IL-4 gene, was the gift of Dr. Kenneth Mur-
allow the further study of Th2 subset diversity. phy. pMEX-Neo and pMEX-maf have been described previously (Ho
et al., 1996).
Experimental Procedures
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Single cell spleen suspensions were incubated at 48C with FITC-
Referencesconjugated anti-CD4 (RM4-4) and PE-conjugated anti-CD62L (MEL-
14) antibody, resuspended in unsupplemented RPMI at 107 cells per
Aversa, G., Punnonen, J., Cocks, B.G., de Waal Malefyt, R., Vega,ml, and sorted using a MoFlo (Cytomation) cell sorter. The CD41
F., Zurawski, S.M., Zurawski, G., and deVries, J.E. (1993). An interleu-and Mel-14 high cells were collected as naive cells and used in in
kin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced humanvitro differentiation assays. The rat anti-mouse FcRgII/III mAb
immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation:(2.4G2) was used to block nonspecific binding.
support for a common component shared by IL-4 and IL-13 recep-
tors. J. Exp. Med. 178, 2213±2218.
In Vitro Differentiation of Th Cells
Barner, M., Mohrs, M., Brombacher, F., and Kopf, M. (1998). Differ-Spleen cells were harvested and stimulated in vitro with plate-bound
ences between IL-4Ra-deficient and IL-4-deficient mice reveal a roleanti-CD3 mAb (2C11) at 1 mg/ml alone and with anti-CD28 (1 mg/
for IL-13 in the regulation of Th2 responses. Curr. Biol. 8, 669±672.ml) for naive T cells (nonskewing conditions) or with anti-IL-12 mAb
Bendelac, A., Hunziker, R.D., and Lantz, O. (1996). Increased in-(5C3) at 20 mg/ml and recombinant IL-4 500 U/ml (Th2-skewing
terleukin 4 and immunoglobulin E production in transgenic miceconditions). Twenty-four hours post stimulation, IL-2 at 50 units/ml
overexpressing NK1 T cells. J. Exp. Med. 184, 1285±1293.was added to all cultures. Seven days post stimulation, cells were
harvested, washed thoroughly, and restimulated with plate-bound Bost, K.L., Holton, R.H., Cain, T.K., and Clements, J.D. (1996). In
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vivo treatment with anti-interleukin-13 antibodies significantly re- Hoshino, T., Winkler-Pickett, R.T., Mason, A.T., Ortaldo, J.R., and
duces the humoral immune response against an oral immunogen Young, H.A. (1999). IL-13 production by NK cells: IL-13-producing
in mice. Immunology 87, 633±641. NK and T cells are present in vivo in the absence of IFN-g. J. Immu-
nol. 162, 51±59.Brown, K.D., Zurawski, S.M., Mosmann, T.R., and Zurawski, G.
(1989). A family of small inducible proteins secreted by leukocytes Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996).
are members of a new superfamily that includes leukocyte and Stat6 is required for mediating responses to IL-4 and for the develop-
fibroblast-derived inflammatory agents, growth factors, and indica- ment of Th2 cells. Immunity 4, 313±319.
tors of various activation processes. J. Immunol. 142, 679±687. Kaplan, M.H., Whitfield, J.R., Boros, D.L., and Grusby, M.J. (1998).
Brown, D.R., Fowell, D.J., Corry, D.B., Wynn, T.A., Moskowitz, N.H., Th2 cells are required for the Schistosoma mansoni egg-induced
Cheever, A.W., Locksley, R.M., and Reiner, S.L. (1996). B2-micro- granulomatous response. J. Immunol. 160, 1850±1856.
globulin-dependent NK1.11 T cells are not essential for T helper Kim, J.I., Li, T., Ho, I., Grusby, M., and Glimcher, L.H. (1999). Require-
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